DOI QR코드

DOI QR Code

Tea consumption is associated with a reduced risk of coronary heart disease in female but not male populations in Guangzhou, China

  • Chen, Ying (Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) ;
  • Ye, Yanfang (Clinical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) ;
  • Zhang, Zhen (Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Zhang, Chi (Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Chen, Minyu (Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Pang, Jun (Department of Cardiology, Guizhou Province People's Hospital) ;
  • Zhou, Shuxian (Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) ;
  • Xiang, Qiuling (Zhongshan School of Medicine, Sun Yat-sen University)
  • Received : 2018.10.25
  • Accepted : 2019.05.31
  • Published : 2019.10.01

Abstract

BACKGROUND/OBJECTIVES: The association between tea consumption and risk of coronary heart disease (CHD) remains controversial. This study aimed to determine whether tea consumption has an effect on CHD risk in Chinese adults. SUBJECTS/METHODS: In this hospital-based case-control study, 267 cases of CHD and 235 non-CHD controls were enrolled. Blood samples from all cases were examined. Cardiac function indices (left ventricular ejection fraction, left ventricular end-diastolic dimension, lactate dehydrogenase, and creatine kinase of the muscle or brain type), blood lipid index (high-density lipoprotein cholesterol), and blood coagulation function indices (fibrinogen and activated partial thromboplastin time) were recorded. Tea consumption of study participants was assessed by a specifically designed questionnaire. The baseline characteristics of the study populations were recorded, and CHD-related biomarkers were detected. Differences in baseline characteristics of the study participants were examined using t-tests for continuous variables and chi-squared tests for categorical variables. Unconditional logistic regression was used to measure the association between tea and CHD. RESULTS: There were significant differences in cardiac function indices, blood lipid index, and blood coagulation indices between CHD cases and controls (P < 0.05). We found tea consumption reduced CHD risk in female participants (adjusted odds ratio (OR) = 0.484, 95% CI: 0.242-0.968, P = 0.0403). Regarding the type of tea consumed, the risk of CHD was reduced in women who drank partially fermented tea (adjusted OR = 0.210, 95% CI: 0.084-0.522, P = 0.0008). Analytic results for the amount of tea consumed per unit time showed CHD risk was reduced in women who consumed 1-2 cups of tea per day (adjusted OR = 0.291, 95% CI: 0.131-0.643, P = 0.0023). A tea-drinking frequency of > 6 days/week was beneficial for CHD prevention (adjusted OR = 0.183, 95% CI: 0.049-0.679, P = 0.0112). When analyzed according to the duration of tea consumption, the risk of CHD was reduced in participants who had been drinking tea for 10-20 years (adjusted OR = 0.360, 95% CI: 0.137-0.946, P = 0.0382). CONCLUSIONS: Tea consumption is associated with a reduced risk of CHD in female but not male populations in Guangzhou.

Keywords

References

  1. Chatterjee P, Chandra S, Dey P, Bhattacharya S. Evaluation of anti-inflammatory effects of green tea and black tea: a comparative in vitro study. J Adv Pharm Technol Res 2012;3:136-8. https://doi.org/10.4103/2231-4040.97298
  2. Subramaniam P, Eswara U, Maheshwar Reddy KR. Effect of different types of tea on Streptococcus mutans: an in vitro study. Indian J Dent Res 2012;23:43-8. https://doi.org/10.4103/0970-9290.99037
  3. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol 2015;30:103-13. https://doi.org/10.1007/s10654-014-9960-x
  4. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, Beulens JW. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 2010;30:1665-71. https://doi.org/10.1161/ATVBAHA.109.201939
  5. Grassi D, Draijer R, Schalkwijk C, Desideri G, D'Angeli A, Francavilla S, Mulder T, Ferri C. Black tea increases circulating endothelial progenitor cells and improves flow mediated dilatation counterac ting deleterious effects from a fat load in hypertensive patients: a randomized controlled study. Nutrients 2016;8:727-37. https://doi.org/10.3390/nu8110727
  6. Hibi M, Takase H, Iwasaki M, Osaki N, Katsuragi Y. Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials. Nutr Res 2018;55:1-10. https://doi.org/10.1016/j.nutres.2018.03.012
  7. Miyazaki R, Kotani K, Ayabe M, Tsuzaki K, Shimada J, Sakane N, Takase H, Ichikawa H, Yonei Y, Ishii K. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial. Geriatr Gerontol Int 2013;13:622-9. https://doi.org/10.1111/j.1447-0594.2012.00952.x
  8. Yan Y, Sui X, Yao B, Lavie CJ, Blair SN. Is there a dose-response relationship between tea consumption and all-cause, CVD, and cancer mortality? J Am Coll Nutr 2017;36:281-6. https://doi.org/10.1080/07315724.2016.1261054
  9. Liu J, Liu S, Zhou H, Hanson T, Yang L, Chen Z, Zhou M. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol 2016;31:853-65. https://doi.org/10.1007/s10654-016-0173-3
  10. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001;154:495-503. https://doi.org/10.1093/aje/154.6.495
  11. Li X, Yu C, Guo Y, Bian Z, Si J, Yang L, Chen Y, Ren X, Jiang G, Chen J, Chen Z, Lv J, Li L; China Kadoorie Biobank Collaborative Group. Tea consumption and risk of ischaemic heart disease. Heart 2017;103:783-9. https://doi.org/10.1136/heartjnl-2016-310462
  12. Chen XQ, Wang XB, Guan RF, Tu J, Gong ZH, Zheng N, Yang JH, Zhang YY, Ying MM. Blood anticoagulation and antiplatelet activity of green tea (-)-epigallocatechin (EGC) in mice. Food Funct 2013;4:1521-5. https://doi.org/10.1039/c3fo60088b
  13. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001;74:227-32. https://doi.org/10.1093/ajcn/74.2.227
  14. Samavat H, Newman AR, Wang R, Yuan JM, Wu AH, Kurzer MS. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial. Am J Clin Nutr 2016;104:1671-82. https://doi.org/10.3945/ajcn.116.137075
  15. Huang LH, Liu CY, Wang LY, Huang CJ, Hsu CH. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, doubleblind, and cross-over placebo-controlled clinical trial. BMC Complement Altern Med 2018;18:294-304. https://doi.org/10.1186/s12906-018-2355-x
  16. Mitchell AE, Burns SA, Rudolf JL. Isozyme- and gender-specific induction of glutathione S-transferases by flavonoids. Arch Toxicol 2007;81:777-84. https://doi.org/10.1007/s00204-007-0210-9
  17. Yamazaki KG, Romero-Perez D, Barraza-Hidalgo M, Cruz M, Rivas M, Cortez-Gomez B, Ceballos G, Villarreal F. Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2008;295:H761-7. https://doi.org/10.1152/ajpheart.00413.2008
  18. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006;296:1255-65. https://doi.org/10.1001/jama.296.10.1255
  19. Satoh E, Tohyama N, Nishimura M. Comparison of the antioxidant activity of roasted tea with green, oolong, and black teas. Int J Food Sci Nutr 2005;56:551-9. https://doi.org/10.1080/09637480500398835
  20. Sands-Lincoln M, Loucks EB, Lu B, Carskadon MA, Sharkey K, Stefanick ML, Ockene J, Shah N, Hairston KG, Robinson JG, Limacher M, Hale L, Eaton CB. Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women's Health Initiative. J Womens Health (Larchmt) 2013;22:477-86. https://doi.org/10.1089/jwh.2012.3918